Event Details
Oppenheimer 35th Annual Healthcare Conference
February 12, 2025
Jonathan Javitt, MD, MPH, Founder, Chairman and Chief Executive Officer of NRx Pharmaceuticals presented a Company update at the Oppenheimer 35th Annual Healthcare Life Sciences Conference, which took place on Wednesday, February 12th, 2025. Watch the webcast here.